Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
McKesson
Colorcon
Johnson and Johnson
McKinsey

Last Updated: September 26, 2022

DESIPRAMINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Desipramine Hydrochloride patents expire, and when can generic versions of Desipramine Hydrochloride launch?

Desipramine Hydrochloride is a drug marketed by Actavis Totowa, Alembic Pharms Ltd, Amneal Pharms Co, Ani Pharms, Heritage Pharms, Novast Labs, Sandoz, and Usl Pharma. and is included in twenty-one NDAs.

The generic ingredient in DESIPRAMINE HYDROCHLORIDE is desipramine hydrochloride. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the desipramine hydrochloride profile page.

Drug patent expirations by year for DESIPRAMINE HYDROCHLORIDE
Recent Clinical Trials for DESIPRAMINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Duke UniversityPhase 4
Stanford UniversityPhase 4
State University of New York at BuffaloPhase 4

See all DESIPRAMINE HYDROCHLORIDE clinical trials

Pharmacology for DESIPRAMINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DESIPRAMINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for DESIPRAMINE HYDROCHLORIDE

US Patents and Regulatory Information for DESIPRAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novast Labs DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 204963-006 Dec 26, 2017 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Heritage Pharms DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 207433-003 May 5, 2016 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Usl Pharma DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 071865-001 Sep 9, 1987 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Dow
Express Scripts
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.